Header Logo

Connection

Julie Schmittdiel to Diabetes Mellitus

This is a "connection" page, showing publications Julie Schmittdiel has written about Diabetes Mellitus.
Connection Strength

9.520
  1. Comment on Dunne et al. The Women's Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734-1743. Diabetes Care. 2022 05 01; 45(5):e97-e98.
    View in: PubMed
    Score: 0.590
  2. A Randomized Encouragement Trial to Increase Mail Order Pharmacy Use and Medication Adherence in Patients with Diabetes. J Gen Intern Med. 2021 01; 36(1):154-161.
    View in: PubMed
    Score: 0.529
  3. Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System. J Gen Intern Med. 2020 01; 35(1):160-166.
    View in: PubMed
    Score: 0.497
  4. Opportunities to encourage mail order pharmacy delivery service use for diabetes prescriptions: a qualitative study. BMC Health Serv Res. 2019 Jun 25; 19(1):422.
    View in: PubMed
    Score: 0.485
  5. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control. J Manag Care Spec Pharm. 2018 Sep; 24(9):856-861.
    View in: PubMed
    Score: 0.458
  6. Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes. Pharmacotherapy. 2017 Oct; 37(10):1204-1214.
    View in: PubMed
    Score: 0.428
  7. Opportunities to Reduce Diabetes Risk in Women of Reproductive Age: Assessment and Treatment of Prediabetes within a Large Integrated Delivery System. Womens Health Issues. 2017 Nov - Dec; 27(6):666-672.
    View in: PubMed
    Score: 0.423
  8. Population Health Management for Diabetes: Health Care System-Level Approaches for Improving Quality and Addressing Disparities. Curr Diab Rep. 2017 05; 17(5):31.
    View in: PubMed
    Score: 0.417
  9. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Med Care. 2015 Apr; 53(4):332-7.
    View in: PubMed
    Score: 0.361
  10. Methods for engaging stakeholders in comparative effectiveness research: a patient-centered approach to improving diabetes care. Healthc (Amst). 2015 Jun; 3(2):80-8.
    View in: PubMed
    Score: 0.360
  11. Medicare Star excludes diabetes patients with poor CVD risk factor control. Am J Manag Care. 2014 Dec 01; 20(12):e573-81.
    View in: PubMed
    Score: 0.353
  12. Impact of a pharmacy benefit change on new use of mail order pharmacy among diabetes patients: the Diabetes Study of Northern California (DISTANCE). Health Serv Res. 2015 Apr; 50(2):537-59.
    View in: PubMed
    Score: 0.346
  13. Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study. J Am Pharm Assoc (2003). 2014 Jul-Aug; 54(4):374-82.
    View in: PubMed
    Score: 0.343
  14. Safety and effectiveness of mail order pharmacy use in diabetes. Am J Manag Care. 2013 Nov; 19(11):882-7.
    View in: PubMed
    Score: 0.328
  15. Patient satisfaction and perceived success with a telephonic health coaching program: the Natural Experiments for Translation in Diabetes (NEXT-D) Study, Northern California, 2011. Prev Chronic Dis. 2013 Oct 31; 10:E179.
    View in: PubMed
    Score: 0.328
  16. Health-plan and employer-based wellness programs to reduce diabetes risk: The Kaiser Permanente Northern California NEXT-D Study. Prev Chronic Dis. 2013; 10:E15.
    View in: PubMed
    Score: 0.309
  17. Patient-provider communication regarding drug costs in Medicare Part D beneficiaries with diabetes: a TRIAD Study. BMC Health Serv Res. 2010 Jun 14; 10:164.
    View in: PubMed
    Score: 0.259
  18. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care. 2010 Mar; 33(3):520-5.
    View in: PubMed
    Score: 0.250
  19. The effectiveness of diabetes care management in managed care. Am J Manag Care. 2009 May; 15(5):295-301.
    View in: PubMed
    Score: 0.240
  20. Medicare Part D coverage gap and diabetes beneficiaries. Am J Manag Care. 2009 Mar; 15(3):189-93.
    View in: PubMed
    Score: 0.237
  21. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008 May; 23(5):588-94.
    View in: PubMed
    Score: 0.221
  22. Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control. Med Care. 2007 Apr; 45(4):315-21.
    View in: PubMed
    Score: 0.208
  23. Choice of a primary care physician and its relationship to adherence among patients with diabetes. Am J Manag Care. 2002 Sep; 8(9):777-84.
    View in: PubMed
    Score: 0.151
  24. Predictors of Hyperkalemia and Hypokalemia in Individuals with Diabetes: a Classification and Regression Tree Analysis. J Gen Intern Med. 2020 08; 35(8):2321-2328.
    View in: PubMed
    Score: 0.128
  25. Incidence of diabetes after a partner's diagnosis. Prev Med. 2017 Dec; 105:52-57.
    View in: PubMed
    Score: 0.107
  26. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-195.
    View in: PubMed
    Score: 0.096
  27. The Comparative Effectiveness of Diabetes Prevention Strategies to Reduce Postpartum Weight Retention in Women With Gestational Diabetes Mellitus: The Gestational Diabetes' Effects on Moms (GEM) Cluster Randomized Controlled Trial. Diabetes Care. 2016 Jan; 39(1):65-74.
    View in: PubMed
    Score: 0.095
  28. Reach and Validity of an Objective Medication Adherence Measure Among Safety Net Health Plan Members with Diabetes: A Cross-Sectional Study. J Manag Care Spec Pharm. 2015 Aug; 21(8):688-98.
    View in: PubMed
    Score: 0.092
  29. Response to comment on O'Connor et al. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes care 2014;37:3317-3324. Diabetes Care. 2015 Mar; 38(3):e46.
    View in: PubMed
    Score: 0.090
  30. Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes. Diabetes Care. 2014 Dec; 37(12):3317-24.
    View in: PubMed
    Score: 0.087
  31. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study. Ann Pharmacother. 2013 Oct; 47(10):1280-91.
    View in: PubMed
    Score: 0.081
  32. Screening for impaired fasting glucose and diabetes using available health plan data. J Diabetes Complications. 2013 Nov-Dec; 27(6):580-7.
    View in: PubMed
    Score: 0.079
  33. Cost-effectiveness of a multicondition collaborative care intervention: a randomized controlled trial. Arch Gen Psychiatry. 2012 May; 69(5):506-14.
    View in: PubMed
    Score: 0.074
  34. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study. Trials. 2010 Oct 12; 11:95.
    View in: PubMed
    Score: 0.066
  35. Primary non-adherence to prescribed medications. J Gen Intern Med. 2010 Aug; 25(8):763; author reply 765.
    View in: PubMed
    Score: 0.065
  36. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc. 2010 May; 58(5):822-8.
    View in: PubMed
    Score: 0.064
  37. Mail-order pharmacy use and adherence to diabetes-related medications. Am J Manag Care. 2010 Jan; 16(1):33-40.
    View in: PubMed
    Score: 0.063
  38. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes. Health Serv Res. 2010 Apr; 45(2):355-75.
    View in: PubMed
    Score: 0.063
  39. The association of patient age with cardiovascular disease risk factor treatment and control in diabetes. J Gen Intern Med. 2009 Sep; 24(9):1049-52.
    View in: PubMed
    Score: 0.061
  40. Implications of different laboratory-based incident diabetic kidney disease definitions on comparative effectiveness studies. J Comp Eff Res. 2014 Jul; 3(4):359-69.
    View in: PubMed
    Score: 0.021
  41. The predictors of patient-physician race and ethnic concordance: a medical facility fixed-effects approach. Health Serv Res. 2010 Jun; 45(3):792-805.
    View in: PubMed
    Score: 0.016
  42. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009 Oct; 44(5 Pt 1):1640-61.
    View in: PubMed
    Score: 0.015
  43. Treatment intensification and risk factor control: toward more clinically relevant quality measures. Med Care. 2009 Apr; 47(4):395-402.
    View in: PubMed
    Score: 0.015
  44. External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. JAMA. 2003 Jan 22-29; 289(4):434-41.
    View in: PubMed
    Score: 0.010
  45. As good as it gets? Chronic care management in nine leading US physician organisations. BMJ. 2002 Oct 26; 325(7370):958-61.
    View in: PubMed
    Score: 0.010

© 2024 Kaiser Permanente